기사 (79건) 리스트형 웹진형 타일형 HER2-positive locally advanced or metastatic breast cancer treatment 'Tukysa' lands in Korea [Newsmp] The Ministry of Food and Drug Safety of South ... Institutional, foreign investors bet on KOSPI pharma stocks, retail investors remain cautious Institutional, foreign investors bet on KOSPI pharma stocks, retail investors remain cautious EnspryngㆍJemperli become reimbursable in South Korea EnspryngㆍJemperli become reimbursable in South Korea Immunotherapy, ADC, and CAR-T therapies in full swing Immunotherapy, ADC, and CAR-T therapies in full swing Big pharma oncology business thrives, MSD posts quarterly revenue of KRW 9 trillion Big pharma oncology business thrives, MSD posts quarterly revenue of KRW 9 trillion GLP-1 drugs emerge as Big Pharma's new growth engine as COVID-19 fades GLP-1 drugs emerge as Big Pharma's new growth engine as COVID-19 fades SemaglutideㆍTirzepatide boom in diabetes treatment market SemaglutideㆍTirzepatide boom in diabetes treatment market Licensed products drive YuhanㆍChong Kun Dang to success Licensed products drive YuhanㆍChong Kun Dang to success Sharp decline in 3Q Korean Orange Book listings, 45 companies, 79 cases Sharp decline in 3Q Korean Orange Book listings, 45 companies, 79 cases South Korea to relax regulations on rare and radioactive drugs [Newsmp] The Ministry of Food and Drug Safety (MFDS) an... JyselecaㆍNucalaㆍCinqairㆍOlimel N receive reimbursement in Korea JyselecaㆍNucalaㆍCinqairㆍOlimel N receive reimbursement in Korea Q3 clinical trial approvals hit 250, down 40% from Q2 Q3 clinical trial approvals hit 250, down 40% from Q2 처음처음이전이전1234567다음다음끝끝